Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F8D9P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,278
Award facts
- Contract value 100% obligated
- $13,278.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Otezla 30 mg tablets (60-count) with a ceiling value of $13,278.25. This firm fixed-price delivery order, which is due for completion by December 10, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor on the DLA Troop Support Medical IDC, the company supplies pharmaceutical products to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Otezla, a specialty medication used in the treatment of psoriasis and psoriatic arthritis, exemplifies the company's role in supporting federal military and veteran healthcare supply chains through competitively awarded contracts with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DR26F8D9P?
SPE2DR26F8D9P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F8D9P worth?
The government has obligated $13,278 on SPE2DR26F8D9P.
Is contract SPE2DR26F8D9P an order under another contract?
Yes. SPE2DR26F8D9P is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8D9P competed?
The extent of competition for SPE2DR26F8D9P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award